MedPath

Allergan Hong Kong Limited

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

17

PPB:17

Drug Approvals

BELKYRA SOLUTION FOR INJECTION 20MG/2ML

Approval Date
Mar 26, 2018
PPB

GANFORT PF EYE DROPS

Approval Date
Oct 10, 2014
PPB

OPTIVE ADVANCED LUBRICANT EYE DROPS

Approval Date
Oct 10, 2014
PPB

OPTIVE SENSITIVE LUBRICANT EYE DROPS

Approval Date
Dec 24, 2012
PPB

BOTOX FOR INJECTION 200 UNITS

Approval Date
Apr 1, 2011
PPB

LUMIGAN OPHTHALMIC SOLUTION 0.01%

Approval Date
Mar 16, 2011
PPB

OZURDEX INTRAVITREAL IMPLANT 700MCG

Approval Date
Jan 19, 2011
PPB

RESTASIS OPHTHALMIC EMULSION 0.05%

Approval Date
May 11, 2009
PPB

OPTIVE LUBRICANT EYE DROPS

Approval Date
Oct 31, 2008
PPB

COMBIGAN EYE DROPS

Approval Date
Jul 21, 2008
PPB
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.